PMID- 8853432 OWN - NLM STAT- MEDLINE DCOM- 19961205 LR - 20191210 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 271 IP - 3 Pt 2 DP - 1996 Sep TI - Autocrine production and TGF-beta 1-mediated effects on metabolism and viability in renal cells. PG - F689-97 AB - Transforming growth factor-beta 1 (TGF-beta 1) treatment (0.2-2.0 ng/ml, 8-80 M) of confluent primary cultures of rabbit renal proximal bular cells (RPTC) for 6 consecutive days resulted in both a benotypic transformation of the monolayer into solid clus- rs of cells and apoptosis. TGF-beta 1 treatment stimulated glycolysis before any effect on monolayer DNA content or morphology. TGF-beta 1 treatment also resulted in a 35% decrease in oxygen consumption, 50% inhibition of Na(+)-K(+)- ATPase activity, and a 57% decrease in gluconeogenesis. A concentration of 0.06 ng/ml TGF-beta 1 decreased oxygen consumption and induced glycolysis but had no effect on morphology and viability of RPTC. Endogenous production of TGF-beta 1 by RPTC increased 2.6-fold during 10 days of culture. Control RPTC treated with anti-TGF-beta antibodies exhibited decreased glycolysis, and lactate metabolism shifted from net production to net consumption. These results show that TGF-beta 1 stimulates glycolysis, decreases respiration, and, at higher concentrations, induces RPTC apoptosis and phenopic changes. Inhibition of net lactate production in cells grown in the presence of anti-TGF-beta antibodies suggests that increased endogenous production of TGF-beta is responsible for the stimulation of glycolysis in long-term cultures of RPTC. FAU - Nowak, G AU - Nowak G AD - Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock 72205-7199, USA. FAU - Schnellmann, R G AU - Schnellmann RG LA - eng GR - ES-04110/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Antibodies) RN - 0 (Hormones) RN - 0 (Transforming Growth Factor beta) RN - EC 7.2.2.13 (Sodium-Potassium-Exchanging ATPase) SB - IM MH - Animals MH - Antibodies/immunology MH - Cell Division MH - Cell Survival MH - Female MH - Gluconeogenesis/drug effects MH - Glycolysis/drug effects MH - Hormones/*metabolism MH - Kidney Tubules, Proximal/cytology/*metabolism MH - Oxygen Consumption/drug effects MH - Rabbits MH - Sodium-Potassium-Exchanging ATPase/metabolism MH - Transforming Growth Factor beta/immunology/pharmacology/*physiology EDAT- 1996/09/01 00:00 MHDA- 1996/09/01 00:01 CRDT- 1996/09/01 00:00 PHST- 1996/09/01 00:00 [pubmed] PHST- 1996/09/01 00:01 [medline] PHST- 1996/09/01 00:00 [entrez] AID - 10.1152/ajprenal.1996.271.3.F689 [doi] PST - ppublish SO - Am J Physiol. 1996 Sep;271(3 Pt 2):F689-97. doi: 10.1152/ajprenal.1996.271.3.F689.